#cannabisaficionado

Culture

MzJill: The Expert Cannabis Cultivator Putting Patients First

We caught up with infamous grower MzJill to talk cannabis genetics, growing in Oregon and the burgeoning legal cannabis industry.

Published

on

MzJill
PHOTO | MzJill
Advertisement Back2Grow Advertisement

If anyone can be considered a cannabis superwoman, it’s MzJill. She began growing cannabis twenty years ago as a single mom with three kids. Now, after trudging through the dark ages of cannabis prohibition, she’s pioneered two game-changing cannabis genetics companies and has helped patients across the west coast find long-awaited moments of peace.

We caught up with the infamous grower to talk cannabis genetics, growing in Oregon and the burgeoning newly-legal cannabis industry.

Meet MzJill

Her first major venture was TGA Genetics. Active until 2017, MzJill and TGA earned their fair share of media attention — High Times featured TGA strains on numerous occasions over the past decade. She was also the first female breeder to do so.

Now, at MzJill Genetics, she’s continuing to craft some of the best cannabis cultivars on the market.

Yet, unlike many who enter into the cannabis game, starting a strain revolution wasn’t what MzJill had in mind when she began growing. “I originally started as a means to provide my own medicine for my scoliosis,” she told us. It didn’t take long, however, before her green thumb began to show its color.

Growing Medicine

“I started helping other people. That’s what really got me going,” explains MzJill. “I had some other patients that were in need of meds, that weren’t as able to grow, or understand how to make cannabis cookies, medicated cookies, or edibles.”

In fact, it was through helping a patient, a woman with multiple sclerosis that needed help setting up a garden, that MzJill developed her first two award-winning strains, Agent Orange and Jilly Bean. Agent Orange was created in honor of MzJill’s father, a Vietnam veteran who developed cancer after being exposed to the toxic herbicide.

MzJill received an Orange Velvet clone through her patient, a plant which then became the mother of her two top-performing cultivars. Orange Velvet itself features a smooth and creamy quality, a subtle and familiar flavor that was passed on to both Agent Orange and Jilly Bean. The flavor and crystal-coated appearance of these plants, however, are not the features that set these plants apart.

MzJill has a history of crafting the perfect plant for a patient in need.

“A lot of people are growing for flavor, for terpenes for concentrates,” MzJill said. “While I still really focus on the flavor of the cannabis, I also want to make sure that I have the medicinal qualities that can help other people.”

The Brian Berry line offers the perfect example. The line, masterfully bred by MzJill Moser Seeds, features eight distinct strains. While these plants can feature impressive yields and many feature a gorgeous purple-tipped coloration, the plants themselves were developed with a different intention in mind: to create truly high-quality medical cannabis.

“The line was named after my friend, Brian Damewood, that passed from ALS [a neurodegenerative diesase]. He was actually able to smoke the very first flower that came from the original Brian Berry Cough three days before he passed.”

Although, MzJill was quick to point out that finding the right plant for a patient’s specific needs is no easy feat. “You can have one strain that can be absolutely fantastic medicine for one person,” she begins, “and the next person can get anxiety or depression from it.”

“So, every strain is not going to be suited for every person. You always have to look and find out what is going to work best for your symptoms and needs.”

Cannabis for Patients First

Given the standout personalities of strains like Black Cherry Soda, Jilly Bean, and Brian Berry, MzJill certainly knows how to create exotic concoctions that work. Yet, selling seeds is only one part of what this experienced breeder actually does.

“We put a lot of love and care into it,” says MzJill. “We don’t just want to rush through it. We take the time to make sure that we are getting the very best female and using her in the cross, and that’s really what we have to do.”

“People are just rushing into it,” she continues, “they’re throwing plants together and not taking the time to stabilize the line. You know, you have a patient and they buy a pack of seeds and they get 10 completely different plants, that’s not very helpful for them.”

Considering that MzJill grew her first plant in 1997, she certainly is the person to ask about expert cannabis cultivation. MzJill got her start when the plant was still illegal in the state of Oregon, although medical cannabis was legalized in the state in 1998. Still, it was a time when cannabis-consuming women faced a real threat of having their children taken away if they were caught cultivating the herb. In many states, this threat is still very real.

Given the high risks, you have to really love what you’re doing to continue. With the big boom in the industry after legalization, however, the community around medical cannabis has changed.

“Now, you have a lot of people who are fresh out of college or a lot of people with a large amount of money who want to invest, and they’re not getting into it for the right reasons,” says MzJill. “They are seeing money signs, they don’t care about the patient. They don’t care about the people who were pioneers of the industry, so I feel that it had more heart before.”

Luckily for patients and cannasseurs alike, MzJill isn’t getting out of the game anytime soon. She and her business partner, Moser Seeds, have several new lines in the making. “We are going to continue to expand,” she says.

“We are working now on the Jilly Bean line, which will have a minimum of five different specific flavors. They will all be Jilly Bean line, for example, Urkle crossed with Jilly Bean will be a Grape Jilly Bean. We are also working on feminized lines, there are quite a lot of new ladies in our library that we are working with.”

In the meantime, MzJill’s advice for new growers in the industry? “If you have a garden, if you’re a successful grower, find one person that you help on a regular basis, and stick with them.”

Culture

Massachusetts Maps a Tentative 2027 Start for Cannabis Lounge Applications

The latest implementation plan separates lounge applications from event-organizer licensing, with local opt-in and operating approvals still central to the process.

Published

on

Lounge chairs and small tables beside indoor plants and glass railings

Massachusetts’s latest cannabis social-consumption implementation materials point to March 2027 for supplemental and hospitality license applications, followed by event-organizer applications in June. The timetable offers a clearer planning horizon for cannabis lounges and related businesses, but it is explicitly tentative. It is not an announcement that particular lounges will open in March or that current venues can begin allowing consumption.

The schedule appears in the Cannabis Control Commission’s November 12, 2026 public-meeting book. Anthony Martinelli reported the projected dates for The Marijuana Herald the same day. The primary presentation also lists unfinished guidance, application, technology and compliance work, explaining why a regulation already on the books has not yet become an operating market.

Three license classes, different settings

The commission’s January announcement established the basic structure. Supplemental licenses are intended to let qualifying existing marijuana establishments add on-site consumption at their business locations. Hospitality licenses create a route for qualifying applicants, including businesses that are not currently cannabis establishments. Event-organizer licenses address temporary consumption events.

Those categories matter because a café, an existing dispensary and a temporary gathering face different practical questions. A business looking for a permanent designated area is not necessarily pursuing the same license or operating plan as an organizer arranging an event. A general reference to cannabis lounges can obscure those distinctions.

The November presentation places supplemental and hospitality applications on the same target launch month, while giving event-organizer work a later milestone. Readers should keep those dates attached to the appropriate category rather than treating June as the timetable for every venue or March as a promise about every event.

Regulations and available applications are separate milestones

The commission says its social-consumption regulations took effect January 2, 2026. Its implementation project then had to develop the machinery that supports licensing: application materials, IT changes, responsible vendor training, inspection requirements, public information and coordination with municipalities.

That sequence explains an apparent contradiction in the public discussion. The existence of regulations does not mean a business can already obtain every necessary license. Equally, the future launch of an application process would not mean all applicants are immediately authorized to open their doors.

The November meeting materials list work on architectural and structural-change forms, consumer information cards, hospitality application and inspection requirements, and event-organizer compliance planning. They also identify review of four responsible-vendor-training applications. Those are implementation steps, not four approved cannabis lounges.

Local permission remains a gate

The commission’s municipal guidance says communities must opt in to social consumption through lawful local action. Municipalities can decide which license classes and consumption-area types to permit. Local authorization is therefore a substantive part of the process, rather than a detail that follows automatically from the state’s timetable.

The meeting materials include a municipal zoning-tracker form intended to help applicants and the public understand local authorization. The form expressly says that submitting information does not constitute commission approval of a specific establishment. A town appearing in a tracker should not be mistaken for an announcement that a named venue is ready to operate.

Host community agreements and other local requirements may also apply. For a prospective operator, that makes the useful planning questions local as well as statewide: what has the municipality authorized, what site requirements apply, and which approvals would still be necessary for the proposed business?

An equity-focused opening period

The commission’s published framework reserves the initial licensing opportunity for qualifying equity participants and specified smaller cannabis business categories. Its January announcement identifies Social Equity Program participants, Certified Economic Empowerment Priority Applicants, microbusinesses and craft marijuana cooperatives.

The announced exclusivity period runs for 36 months beginning when at least one licensee in each social-consumption class has received authorization to commence operations. It should not be described as a period that simply began when the regulations took effect in January. The trigger affects how the initial opportunity is understood.

What the next update needs to show

The November presentation identifies staffing capacity, technology requirements, competing initiatives and project-management demands as risks. Its target dates are therefore best read as planning milestones that depend on completing the remaining work, not guaranteed opening dates.

For readers following our Harvest Cup coverage, the broader point is also useful: a cannabis-oriented event and an authorized consumption setting are different things. A festival’s theme does not establish its permissions. Massachusetts’s developing system is intended to create a defined route for particular licensed settings.

The next meaningful evidence will be finalized applications and guidance, clear local authorization, and later notices allowing individual operators to commence operations. Until then, March and June provide a tentative map of the licensing project—not an invitation to assume that consumption is permitted at an existing café, hotel or event.

Illustrative hospitality-interior stock photograph; not a Massachusetts cannabis lounge or an approved consumption site. Photo: Tamara B / Unsplash.

Continue Reading

Culture

London’s Cannabis Industry Awards Put the People Behind the Sector in Focus

The Cannabis Industry Council’s November 11 London awards recognize work in patient care, science, advocacy and professional standards.

Published

on

Tables set with glassware and flowers in a banquet room

The Cannabis Industry Council’s awards dinner is scheduled for tonight, November 11, at the Honourable Artillery Company in London. Its cannabis connection is direct: the evening recognizes people working across the UK’s medical cannabis sector, from patient support and pharmacy to research, environmental practice and leadership.

The organizer’s current event page confirms the Wednesday date and venue. This is a preview of the published program, not a report from inside the ceremony. No award recipient should be inferred from a shortlist before the council announces the results.

Nominations for this edition closed in September. An event page that still describes nomination opportunities should not be read as a new chance to enter tonight’s awards; the current timetable and ceremony information take precedence.

Recognition extends beyond a company’s name

The council’s original nominations announcement says the awards recognize individuals rather than companies. That gives the evening a different emphasis from a product competition or a ranking of cannabis brands. The subject is the work people contribute to the sector.

That distinction matters in an industry where consumers often encounter a clinic, product or retailer before learning who supports the service. An individual award can draw attention to work that sits behind a familiar business name without establishing that the entire company is superior to every alternative.

The format also creates room for contributions that are difficult to summarize through sales figures. Helping someone navigate a service, improving a professional process or explaining evidence can matter even when those activities do not produce a headline about a large commercial deal.

Eight categories describe a broad professional community

The published categories include Unsung Hero, the Hannah Deacon Doctor of the Year, Contribution to Social Impact, Pharmacist of the Year, Contribution to Science, the Green Award, Customer Service and Industry Leader of the Year. Together, they place clinical, scientific and operational work alongside advocacy and environmental concerns.

The award named for Hannah Deacon recognizes patient care, according to the council’s description. The science category concerns contributions to understanding cannabis, while the environmental category addresses sustainability. Those are distinct kinds of achievement, and an award in one category should not be read as proof of an unrelated claim.

For example, recognition for customer service would not constitute a clinical trial, just as a scientific contribution would not tell a prospective patient everything about a clinic’s appointment process. The category is part of the meaning of the recognition, not a detail to drop from the eventual winners list.

The judges describe evidence as part of the standard

In the council’s introduction to its judging panel, judges emphasize demonstrated contribution, professional standards and delivery rather than visibility alone. The listed panel includes Professor Mike Barnes, Jamie Bartley, Frances Crewdson, Tom Gray, Nick Pateras, Callie Seaman, Luisa Searle and Heidi Whitman.

These are the organizers’ stated criteria and their panel’s perspectives. They explain what the competition aims to recognize; they are not an independent audit of every nominee’s work. Readers can value professional recognition while still asking what specific contribution led to it.

The useful follow-up after an awards night is therefore more than the name of the winner. What did the person do? Who benefited? What evidence supports the achievement? Those questions turn an honor into a story readers can understand rather than simply repeat.

A formal evening with a practical focus

The event is presented as an awards dinner with entertainment and networking. The current page invites guests to dress for the occasion but says a formal black-tie dress code is not required. Attendees should use the organizer’s current listing for access and practical details rather than assume an older ticket offer remains available.

That presentation places cannabis professionals in a familiar cultural setting: a shared evening recognizing peers. The interest lies in how a developing sector chooses to describe good work and which kinds of contribution it brings into public view.

Our preview of MEDICA’s cannabis-counseling workshop follows another professional gathering, with a different purpose and audience. Training, research and recognition are separate activities, but each can reveal what a cannabis-related professional community considers important.

Wait for the results, then look at the work

The council’s published timetable places the ceremony after the nomination and judging periods. The current story is that the event is scheduled to take place, not that a particular person has won. A results report will require an actual announcement from the organizer.

For now, the evening’s structure offers a clear view of the subjects being celebrated: patient-facing work, scientific understanding, responsible operations and leadership. The most meaningful coverage after the ceremony will connect those category names to concrete achievements, keeping the contribution in focus alongside the celebration.

Illustrative banquet photograph; not the HAC or the Cannabis Industry Awards. Photo: Filip Rankovic Grobgaard / Unsplash.

Continue Reading

Culture

Vermont Opens Its Cannabis Event Lottery Window November 16

A regional lottery will select retailers for the next stage of Vermont’s event-sales pilot, with local approval and detailed operating plans still required.

Published

on

Autumn trees and hills near Mount Mansfield in Stowe, Vermont

Vermont cannabis retailers will soon be able to enter a lottery for a pilot program that could move regulated sales beyond the conventional dispensary. The Cannabis Control Board says the submission window opens November 16 and closes November 30, 2026, with a regional drawing planned for its December 16 meeting.

The cannabis connection is the substance of the program: selected retailers can seek permission to administer off-site events where registered cannabis products are displayed and sold. That is a more limited proposition than an open-consumption festival. The adopted procedure expressly preserves Vermont’s prohibition on public cannabis consumption.

The board’s official events pilot page sets out the dates and application route. Its procedure adopted October 28 explains what applicants must demonstrate before a permit can become an actual event.

A lottery entry is not an event permit

The first step is a preliminary application from a qualified retail cannabis establishment. There is no fee to enter the lottery. The board nevertheless asks businesses to enter only after reviewing the requirements and deciding they have both the capacity and intention to host a compliant event.

The procedure divides the state into five regions and requires a retailer to apply within the region where it is located, for an event in that region. For each region, a final applicant is selected from qualified preliminary applicants by lottery. The procedure also allows first and second runners-up to be selected.

Selection leads to the full application stage, rather than automatically authorizing sales. That later application includes required documentation, standard-form municipal approval and a $500 application fee. Final approval is determined by a board vote. The procedure allows no more than ten event permits per year, a ceiling that should not be confused with a promise that ten events have already been approved.

Local approval and retail experience matter

An event can take place only in a municipality that has voted to authorize cannabis retail sales. The applicant must also obtain written approval for the planned event from the relevant municipal authority. That approval can include conditions addressing public protection, traffic and nuisance concerns.

Applicants must demonstrate good standing and tax compliance. The procedure’s definition includes at least six months of continuous, compliant operation, an appropriate compliance history and reliable recordkeeping. A newly imagined event concept, without the required retail credentials and operating capacity, is therefore not enough.

The operational burden also reaches the retailer’s existing shop. Except for the specified case of an event contiguous with the licensed retail location, a permit holder cannot conduct sales at its shop and the event simultaneously. Businesses weighing participation will need to consider staffing and the effect on normal operations.

Culture can be part of the setting

The procedure allows the board to authorize responsible integration with commercial and cultural offerings. It gives examples including musical artists and vendors serving food or nonalcoholic beverages. Vendors and their employees working at the event must be at least 21, and vendors must hold any other required permits or licenses.

Those possibilities do not remove the program’s boundaries. Settings that sell or furnish alcohol for on-premises consumption are unsuitable, as are settings that appeal to people under 21 or encourage the expectation that public cannabis consumption is authorized. The procedure also identifies activities requiring heightened coordination or judgment, such as the start of a sporting competition, as problematic contexts.

For readers following events such as The Harvest Cup in Massachusetts, the distinction is useful: a cannabis-oriented gathering and a government permit to sell cannabis are separate questions. Vermont’s pilot creates a specific approval route, not a general rule for every cultural event.

The practical plans behind a public event

Security and product-sale plans must explain how inventory, money, staff and access will be managed. The rules address preventing entry by intoxicated people and anyone under 21, protecting products from diversion, and keeping cannabis products out of general public view. They also require inventory tracking arrangements, including accurate records if connectivity is lost.

The product plan has a further market-access requirement: at least 40 percent must meet the procedure’s unaffiliated-product standard, applied by stock-keeping units within specified product categories. Medical cannabis products cannot be promoted or sold at an event. Liability insurance must cover the event location and activities.

For now, November’s deadline is a preparation milestone. No event date, location or participant list follows automatically from it. The next meaningful development will be the regional selection, followed by complete applications and board decisions that show what this tightly bounded experiment will look like in practice.

Stock landscape photograph of Stowe, Vermont; not a proposed or approved cannabis event site. Photo: Rafael Rodrigues / Unsplash.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.